Cancer Genome Landscapes
暂无分享,去创建一个
[1] W. M. Barclay. Surgery , 1894, Bristol medico-chirurgical journal.
[2] A. Chadli. THE CANCER CELL , 1924, La Presse medicale.
[3] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[4] R. Kerbel. Growth dominance of the metastatic cancer cell: cellular and molecular aspects. , 1990, Advances in cancer research.
[5] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[6] AC Tose. Cell , 1993, Cell.
[7] G. Capellá,et al. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas. , 1993, Journal of the National Cancer Institute.
[8] M. Gerretsen,et al. Br. J. Cancer , 1993 .
[9] Scott E. Kern,et al. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers , 1996, Nature Genetics.
[10] Bert Vogelstein,et al. Gatekeepers and caretakers , 1997, Nature.
[11] Hans Clevers,et al. Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.
[12] R. Quatrano. Genomics , 1998, Plant Cell.
[13] A. Sparks,et al. Identification of c-MYC as a target of the APC pathway. , 1998, Science.
[14] 김삼묘,et al. “Bioinformatics” 특집을 내면서 , 2000 .
[15] S. Elledge,et al. The DNA damage response: putting checkpoints in perspective , 2000, Nature.
[16] K. Kinzler,et al. Genetic Testing-- Present and Future , 2000, Science.
[17] S. Gallinger,et al. Microsatellite instability, mismatch repair deficiency, and colorectal cancer. , 2001, Surgery.
[18] Robert A. Weinberg,et al. Metastasis genes: A progression puzzle , 2002, Nature.
[19] Hans Clevers,et al. The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells , 2002, Cell.
[20] Mattias Höglund,et al. Coping with complexity. multivariate analysis of tumor karyotypes. , 2002, Cancer genetics and cytogenetics.
[21] Hans Clevers,et al. Notch1 functions as a tumor suppressor in mouse skin , 2003, Nature Genetics.
[22] Andrew P. Weng,et al. Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.
[23] J. Aster,et al. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling , 2004, Current opinion in hematology.
[24] P. Armitage,et al. The Age Distribution of Cancer and a Multi-stage Theory of Carcinogenesis , 1954, British Journal of Cancer.
[25] D. Lane,et al. Transcription — guarding the genome by sensing DNA damage , 2004, Nature Reviews Cancer.
[26] Michelle R. Arkin,et al. Small-molecule inhibitors of protein–protein interactions: progressing towards the dream , 2004, Nature Reviews Drug Discovery.
[27] A. Feinberg,et al. The history of cancer epigenetics , 2004, Nature Reviews Cancer.
[28] Ericka Stricklin-Parker,et al. Ann , 2005 .
[29] H. Lane,et al. ERBB receptors and cancer: the complexity of targeted inhibitors , 2005, Nature Reviews Cancer.
[30] 刘金明,et al. IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW,Thompson RW,et al//Proc Natl Acad Sci U S A , 2005 .
[31] Dominik Wodarz,et al. Drug resistance in cancer: principles of emergence and prevention. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Tchinda,et al. Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer , 2005, Science.
[33] Alan Ashworth,et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy , 2005, Nature.
[34] Lucio Luzzatto,et al. A quantitative measurement of the human somatic mutation rate. , 2005, Cancer research.
[35] Yan Zhang,et al. CanPredict: a computational tool for predicting cancer-associated missense mutations , 2007, Nucleic Acids Res..
[36] H. Aburatani,et al. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer , 2007, Nature.
[37] Daniel A. Haber,et al. Epidermal growth factor receptor mutations in lung cancer , 2007, Nature Reviews Cancer.
[38] Peter A. Jones,et al. The Epigenomics of Cancer , 2007, Cell.
[39] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[40] James M. Roberts,et al. CDK Inhibitors : Cell Cycle Regulators and Beyond , 2008 .
[41] Martin A. Nowak,et al. Comparative lesion sequencing provides insights into tumor evolution , 2008, Proceedings of the National Academy of Sciences.
[42] C. Yeang,et al. Combinatorial patterns of somatic gene mutations in cancer , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[43] G. Parmigiani,et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.
[44] K. Kinzler,et al. Epitope landscape in breast and colorectal cancer. , 2008, Cancer research.
[45] John G Doench,et al. Kinase requirements in human cells: I. Comparing kinase requirements across various cell types , 2008, Proceedings of the National Academy of Sciences.
[46] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[47] Jeffrey Wyckoff,et al. Differential enhancement of breast cancer cell motility and metastasis by helical and kinase domain mutations of class IA phosphoinositide 3-kinase. , 2009, Cancer research.
[48] G. Parmigiani,et al. Design and analysis issues in genome-wide somatic mutation studies of cancer. , 2009, Genomics.
[49] T. Kunkel. Evolving views of DNA replication (in)fidelity. , 2009, Cold Spring Harbor symposia on quantitative biology.
[50] R. Rosenfeld. Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[51] J. Soulier,et al. Mutation in TET2 in myeloid cancers. , 2009, The New England journal of medicine.
[52] Leyla Isik,et al. Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. , 2009, Cancer research.
[53] K. Kinzler,et al. Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells , 2009, Science.
[54] Ryan D. Morin,et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution , 2009, Nature.
[55] Kun-Liang Guan,et al. Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α , 2009, Science.
[56] L. Liau,et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.
[57] R. McLendon,et al. IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.
[58] Gurpreet W. Tang,et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes , 2009, Nature.
[59] Roberta Pereira NiquiniI,et al. Rev Saúde Pública , 2010 .
[60] Tian-Li Wang,et al. Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma , 2010, Science.
[61] Joshua F. McMichael,et al. DNMT3A mutations in acute myeloid leukemia. , 2010, The New England journal of medicine.
[62] D. Schadendorf,et al. Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.
[63] Rational use of anticancer drugs and patient lawsuits in the state of São Paulo, Southeastern Brazil. , 2010, Revista de saude publica.
[64] Andrew Menzies,et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer , 2010, Nature.
[65] Jeffrey W. Clark,et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. , 2010, The New England journal of medicine.
[66] M. Nowak,et al. Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.
[67] Raymond Sawaya,et al. Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[68] H. Ohtsuki,et al. Accumulation of driver and passenger mutations during tumor progression , 2009, Proceedings of the National Academy of Sciences.
[69] Richard Durrett,et al. Evolution of Resistance and Progression to Disease during Clonal Expansion of Cancer , 2009 .
[70] N. Turner,et al. Fibroblast growth factor signalling: from development to cancer , 2010, Nature Reviews Cancer.
[71] Silvio Barberato-Filho,et al. Uso racional de medicamentos antineoplásicos y acciones judiciales en el estado de Sao Paulo, Sureste de Brasil , 2010 .
[72] Omar Abdel-Wahab,et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. , 2010, Cancer cell.
[73] M. Kastan,et al. Multiple roles of ATM in monitoring and maintaining DNA integrity , 2010, FEBS letters.
[74] J. Schlessinger,et al. Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.
[75] S. Gabriel,et al. Advances in understanding cancer genomes through second-generation sequencing , 2010, Nature Reviews Genetics.
[76] R. Reddel,et al. Alternative lengthening of telomeres: models, mechanisms and implications , 2010, Nature Reviews Genetics.
[77] Richard A. Moore,et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. , 2010, The New England journal of medicine.
[78] Luca Toschi,et al. Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC. , 2010, Cancer cell.
[79] D. Brock. Ethical and value issues in insurance coverage for cancer treatment. , 2010, The oncologist.
[80] K. Anderson,et al. Genetic variegation of clonal architecture and propagating cells in leukaemia , 2011, Nature.
[81] Michael A. Choti,et al. DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors , 2011, Science.
[82] Nikhil Wagle,et al. Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[83] Steven J. M. Jones,et al. Frequent mutation of histone modifying genes in non-Hodgkin lymphoma , 2011, Nature.
[84] Dennis B. Troup,et al. NCBI GEO: archive for functional genomics data sets—10 years on , 2010, Nucleic Acids Res..
[85] M. Pelizzola,et al. The DNA methylome , 2011, FEBS letters.
[86] Napoleone Ferrara,et al. Developmental and pathological angiogenesis. , 2011, Annual review of cell and developmental biology.
[87] A. Hauschild,et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. , 2011, The New England journal of medicine.
[88] Kristian Cibulskis,et al. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion , 2011, Nature Genetics.
[89] P. J. van der Zaag,et al. Targeted enrichment of genomic DNA regions for next-generation sequencing , 2011, Briefings in functional genomics.
[90] Govind Bhagat,et al. Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. , 2011, Cancer cell.
[91] Raul Rabadan,et al. Analysis of the Coding Genome of Diffuse Large B-Cell Lymphoma , 2011, Nature Genetics.
[92] R. Gibbs,et al. Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 , 2011, Science.
[93] Mehmet Toner,et al. Circulating tumor cells: approaches to isolation and characterization , 2011, The Journal of cell biology.
[94] J. Troge,et al. Tumour evolution inferred by single-cell sequencing , 2011, Nature.
[95] Zev A. Binder,et al. The Genetic Landscape of the Childhood Cancer Medulloblastoma , 2011, Science.
[96] A. Ashworth,et al. Therapeutic potential of PARP inhibitors for metastatic breast cancer , 2011, Expert review of anticancer therapy.
[97] A. McKenna,et al. The Mutational Landscape of Head and Neck Squamous Cell Carcinoma , 2011, Science.
[98] Peter Greenwald,et al. Biomarkers for early detection and as surrogate endpoints in cancer prevention trials: issues and opportunities. , 2011, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[99] Zhengyan Kan,et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer , 2011, Nature Genetics.
[100] S. Sugano,et al. Frequent pathway mutations of splicing machinery in myelodysplasia , 2011, Nature.
[101] N. Carter,et al. Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.
[102] Mingming Jia,et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..
[103] Dai Fukumura,et al. Scaling rules for diffusive drug delivery in tumor and normal tissues , 2011, Proceedings of the National Academy of Sciences.
[104] R. McLendon,et al. Altered Telomeres in Tumors with ATRX and DAXX Mutations , 2011, Science.
[105] Richard Simon,et al. Identifying cancer driver genes in tumor genome sequencing studies , 2011, Bioinform..
[106] M. Stratton,et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. , 2011, The New England journal of medicine.
[107] Michael Gundry,et al. Direct mutation analysis by high-throughput sequencing: from germline to low-abundant, somatic variants. , 2012, Mutation research.
[108] E. Mardis,et al. Cancer Exome Analysis Reveals a T Cell Dependent Mechanism of Cancer Immunoediting , 2012, Nature.
[109] David T. W. Jones,et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.
[110] T. Jacks,et al. Expression of tumour-specific antigens underlies cancer immunoediting , 2011, Nature.
[111] J. Castle,et al. Exploiting the mutanome for tumor vaccination. , 2012, Cancer research.
[112] Gerald C. Chu,et al. Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.
[113] A. Børresen-Dale,et al. The landscape of cancer genes and mutational processes in breast cancer , 2012, Nature.
[114] A. Børresen-Dale,et al. The Life History of 21 Breast Cancers , 2012, Cell.
[115] Lilia M. Iakoucheva,et al. Whole-Genome Sequencing in Autism Identifies Hot Spots for De Novo Germline Mutation , 2012, Cell.
[116] C. Sander,et al. Mutual exclusivity analysis identifies oncogenic network modules. , 2012, Genome research.
[117] Rachelle J Bienstock,et al. Computational drug design targeting protein-protein interactions. , 2012, Current pharmaceutical design.
[118] Benjamin J. Raphael,et al. The Mutational Landscape of Lethal Castrate Resistant Prostate Cancer , 2012, Nature.
[119] Michael A. Davies,et al. Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents , 2012, Clinical Cancer Research.
[120] Yuchen Jiao,et al. Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. , 2012, Cancer discovery.
[121] Steven J. M. Jones,et al. Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.
[122] Boping Zhou,et al. Exome sequencing of hepatitis B virus–associated hepatocellular carcinoma , 2012, Nature Genetics.
[123] Norbert Perrimon,et al. Signaling mechanisms controlling cell fate and embryonic patterning. , 2012, Cold Spring Harbor perspectives in biology.
[124] Michael Wigler,et al. A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions , 2012, Proceedings of the National Academy of Sciences.
[125] Huanming Yang,et al. Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor , 2012, Cell.
[126] Joshua F. McMichael,et al. The Origin and Evolution of Mutations in Acute Myeloid Leukemia , 2012, Cell.
[127] M. Meyerson,et al. Recurrent Hemizygous Deletions in Cancers May Optimize Proliferative Potential , 2012, Science.
[128] Meng Li,et al. Somatic Mutations in the Chromatin Remodeling Gene ARID1A Occur in Several Tumor Types , 2011, Human mutation.
[129] Lincoln D. Stein,et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes , 2012, Nature.
[130] Robert Gentleman,et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer , 2012, Nature Genetics.
[131] E. Laurenti,et al. Molecular and functional characterization of early human hematopoiesis , 2012, Annals of the New York Academy of Sciences.
[132] P. A. Futreal,et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.
[133] Graham A. Colditz,et al. Applying What We Know to Accelerate Cancer Prevention , 2012, Science Translational Medicine.
[134] T. Hoppo,et al. The mouse lymph node as an ectopic transplantation site for multiple tissues , 2012, Nature Biotechnology.
[135] Joshua F. McMichael,et al. Whole Genome Analysis Informs Breast Cancer Response to Aromatase Inhibition , 2012, Nature.
[136] Li Ding,et al. Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers , 2012, Cell.
[137] Marc A. Beal,et al. Whole genome sequencing for quantifying germline mutation frequency in humans and model species: cautious optimism. , 2012, Mutation research.
[138] David C. Smith,et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.
[139] P. J. van der Zaag,et al. Using a priori knowledge to align sequencing reads to their exact genomic position , 2011, Nucleic acids research.
[140] J. Kirkwood,et al. Immunotherapy of cancer in 2012 , 2012, CA: a cancer journal for clinicians.
[141] Li Ding,et al. RECURRENT MUTATIONS IN THE U2AF1 SPLICING FACTOR IN MYELODYSPLASTIC SYNDROMES , 2011, Nature Genetics.
[142] R. Medema,et al. Checkpoint control and cancer , 2012, Oncogene.
[143] A. Viale,et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype , 2012, Nature.
[144] Johannes G. Reiter,et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers , 2012, Nature.
[145] Gholamreza Haffari,et al. Feature-based classifiers for somatic mutation detection in tumour–normal paired sequencing data , 2011, Bioinform..
[146] Li Ding,et al. Somatic Histone H3 Alterations in Paediatric Diffuse Intrinsic Pontine Gliomas and Non-Brainstem Glioblastomas , 2012, Nature Genetics.
[147] Yun Ye,et al. Association between KRAS codon 13 mutations and clinical response to anti-EGFR treatment in patients with metastatic colorectal cancer: results from a meta-analysis , 2012, Cancer Chemotherapy and Pharmacology.
[148] S. Berger,et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation , 2012, Nature.
[149] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[150] Angela N. Brooks,et al. Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing , 2012, Cell.
[151] A. Børresen-Dale,et al. Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.
[152] Lynda Chin,et al. Highly Recurrent TERT Promoter Mutations in Human Melanoma , 2013, Science.
[153] D. Schadendorf,et al. TERT Promoter Mutations in Familial and Sporadic Melanoma , 2013, Science.
[154] Andrea Sottoriva,et al. Single-molecule genomic data delineate patient-specific tumor profiles and cancer stem cell organization. , 2013, Cancer research.
[155] Andreas Keller,et al. From next-generation sequencing alignments to accurate comparison and validation of single-nucleotide variants: the pibase software , 2012, Nucleic acids research.
[156] B. Bernstein,et al. Epigenetic Reprogramming in Cancer , 2013, Science.
[157] Peter Donnelly,et al. Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas , 2012, Nature Genetics.
[158] Howard L McLeod,et al. Cancer Pharmacogenomics: Early Promise, But Concerted Effort Needed , 2013, Science.
[159] Giovanni Parmigiani,et al. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation , 2013, Proceedings of the National Academy of Sciences.
[160] I. Tomlinson,et al. Whole-genome methylation analysis of benign and malignant colorectal tumours , 2013, The Journal of pathology.
[161] Andrew M. K. Brown,et al. Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer , 2013, Science.
[162] William G. Wadsworth,et al. This copy is for your personal, non-commercial use only. , 2014 .